uu.seUppsala University Publications
Change search
ReferencesLink to record
Permanent link

Direct link
The expression of cellular retinoid binding proteins in non-APL leukemic cells and its association with retinoid sensitivity
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Medical Sciences. (Dermatologi och venereologi)
2002 (English)In: Leukemia and Lymphoma, ISSN 1042-8194, Vol. 43, no 4, 851-8 p.Article in journal (Other academic) Published
Abstract [en]

Retinoic acid (RA) has important effects on cell differentiation and cell growth and on normal embryonic development. Intracellular retinoid signaling induced by endogenous or exogenous RA is regulated by retinoid binding proteins such as CRBPI, CRABPI and CRABPII and there are data suggesting that the expression of these proteins can influence the sensitivity to the growth inhibitory effects of ATRA. In this study, we investigated the basal and ATRA-induced expression of CRBPI and CRABPI and II in leukemic cell lines and in cells from patients with acute myeloid leukemia (AML). CRBPI as well as CRABPI and II were expressed in all tested cell lines and in leukemic cells from all 18 AML-patients. CRABPII mRNA expression was more abundant than CRBPI and CRABPI in both the cell lines and the patient cells but the levels compared the house keeping gene was lower in the patient cells. In all cell lines and in 69% of the patient samples, ATRA did upregulate CRABPII whereas CRBPI exhibited a varying response and CRABPI was more commonly downregulated. The sensitivity to the growth inhibitory effects of ATRA did not correlate with the basal expression of any of these proteins. However, ATRA-induced upregulation of CRABPII did significantly correlate with the ATRA sensitivity (p < 0.005) as well as with ATRA-induced upregulation of the retinoid receptor RARbeta (p < 0.05). We conclude that the retinoid binding proteins CRBPI and CRABPI and II are expressed in myeloid leukemic cells of non-M3 type but that the level of expression does not affect ATRA sensitivity.

Place, publisher, year, edition, pages
2002. Vol. 43, no 4, 851-8 p.
Keyword [en]
Gene Expression, Humans, Leukemia/drug therapy/*metabolism, RNA; Messenger/analysis, Receptors; Retinoic Acid/analysis/*genetics, Research Support; Non-U.S. Gov't, Retinol-Binding Proteins/analysis/*genetics, Tretinoin/*therapeutic use, Tumor Cells; Cultured, Up-Regulation
National Category
Medical and Health Sciences
URN: urn:nbn:se:uu:diva-73707DOI: 10.1080/10428190290016999PubMedID: 12153175OAI: oai:DiVA.org:uu-73707DiVA: diva2:101617
Available from: 2005-06-14 Created: 2005-06-14Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full textPubMedhttp://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Retrieve&list_uids=12153175&dopt=Citation

Search in DiVA

By author/editor
Törmä, Hans
By organisation
Department of Medical Sciences
In the same journal
Leukemia and Lymphoma
Medical and Health Sciences

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 88 hits
ReferencesLink to record
Permanent link

Direct link